At a meeting in the EU Standing Committee on Plants, Animals, Food and Feed (PAFF) on 11 September, all EU member states were asked to provide the EU Commission with information on gene editing techniques and the recent EU court ruling on mutagenesis. The Swedish Board of Agriculture (SBA) has now responded with a set of crucial questions, such as:
- Concern for the costs and practical possibilities to set up analytical detection procedures for products resulting from new mutagenesis methods
- How long will it take before a technique has a long safety record, as stipulated in Recital 17 of the GMO release directive?
- How should the phrase “used in a number of applications” be interpreted (of Recital 17)?
- Does the Commission interpret the ECJ ruling in such a way that all development in methodology should automatically lead to a regulated GMO?
- If the safety of an organism cannot be determined based on the molecular changes that it contains and by comparison to other organisms which are know to be safe and which contain the same molecular changes, then how it that supposed to be done?
- Is there a procedure on how to determine the risks or the safety of a method?
- Will the Commission analyse the consequences of the ECJ ruling in relation to the WTO agreements?
Read the letter from the SBA here: